Mepolizumab as an effective treatment in a case of hypophysitis in eosinophilic granulomatosis with polyangiitis
Granulomatosis or eosinophilic granulomatosis with polyangiitis (GPA/EGPA) can affect multiple organs resulting in heterogeneous symptoms and phenotypes. Pituitary gland dysfunction rarely occurs in GPA (1–3%) and even less in EGPA (two case reports). Here, we report a case of a 51-year-old female p...
Main Authors: | Jessy Chen, Tobias Alexander, Thula Walter-Rittel, Athanasia Ziagaki, Volker Siffrin |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-06-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/17562864231182519 |
Similar Items
-
Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis
by: Wechsler, M, et al.
Published: (2017) -
Real-life efficacy and safety of mepolizumab for eosinophilic granulomatosis with polyangiitis
by: Giuseppe A. Ramirez, et al.
Published: (2022-12-01) -
Successful concomitant therapy with mepolizumab and dupilumab for atypical eosinophilic granulomatosis with polyangiitis
by: Moriyasu Anai, et al.
Published: (2022-04-01) -
Effectiveness and safety of mepolizumab in combination with corticosteroids in patients with eosinophilic granulomatosis with polyangiitis
by: Masanobu Ueno, et al.
Published: (2021-03-01) -
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis
by: Charlene Desaintjean, et al.
Published: (2024-03-01)